Major Corporations Weigh In As Drug Pricing Debate Continues

October 4, 2021

Major American corporations are split in half as the drug pricing debate continues. One camp, led by the U.S. Chamber of Commerce, protests any drug pricing reform while an opposing group recognizes potential economic benefits for their employees.

“The biggest-spending lobbying organization in the country, the U.S. Chamber of Commerce, adamantly opposes Democrats’ ideas for drug pricing reform, saying they are unwelcome government price controls.But other groups representing the largest businesses in the country, including Walmart, Tesla, Apple, Microsoft, IBM, Boeing, and The Walt Disney Company, have demanded wide-reaching reforms to help lower the cost of insuring their employees.” Read more here.

(Source: Rachel Cohrs, STAT News, 9/28/21)

Share This Story!